X
Business

IBM, Mayo Clinic to create diagnosis database

Technology from IBM will soon help guide doctors at the Mayo Clinic through patient diagnosis and demographic analysis as part of a jointly developed database. Big Blue announced Monday that it will develop a system for the prestigious not-for-profit health care organization designed help archive medical information and make diagnoses and treatments more accurate. The system will be based on IBM's DB2 database software and include new technologies designed specifically for the Mayo Clinic. "This will be one of the most comprehensive and complex information systems ever developed for clinical investigation, designed to help investigators understand illnesses on a molecular level and support improved treatment decisions," said Jeff Augen, director of strategy for IBM Life Sciences, in a press release. The technology will give the Rochester, Minn.-based Mayo Clinic faster access to information that can identify patients for clinical trials, analyze medical data to devise treatment plans and draw meaning from genomic data. The information accessed by the new system will come from public and private databases but will only be collected from consenting patients, according to IBM. The Mayo Clinic, which sees more than 500,000 patients a year, has a staff of some 2,400 doctors and scientists. --Tiffany Kary, Special to ZDNet News
Written by Tiffany Kary, Contributor
Technology from IBM will soon help guide doctors at the Mayo Clinic through patient diagnosis and demographic analysis as part of a jointly developed database.

Big Blue announced Monday that it will develop a system for the prestigious not-for-profit health care organization designed help archive medical information and make diagnoses and treatments more accurate. The system will be based on IBM's DB2 database software and include new technologies designed specifically for the Mayo Clinic.

"This will be one of the most comprehensive and complex information systems ever developed for clinical investigation, designed to help investigators understand illnesses on a molecular level and support improved treatment decisions," said Jeff Augen, director of strategy for IBM Life Sciences, in a press release.

The technology will give the Rochester, Minn.-based Mayo Clinic faster access to information that can identify patients for clinical trials, analyze medical data to devise treatment plans and draw meaning from genomic data. The information accessed by the new system will come from public and private databases but will only be collected from consenting patients, according to IBM. The Mayo Clinic, which sees more than 500,000 patients a year, has a staff of some 2,400 doctors and scientists. --Tiffany Kary, Special to ZDNet News

Editorial standards